Ghost Tree Capital, LLC Portfolio Holdings
Ghost Tree Capital, LLC
- $267 Million
- Q3 2024
Ghost Tree Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $267 Million distributed in 54 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Sarepta Therapeutics, Inc. with a value of $15M, Novo Nordisk A S with a value of $13.1M, Blueprint Medicines Corp with a value of $12.9M, Axsome Therapeutics, Inc. with a value of $12.1M, and Tarsus Pharmaceuticals, Inc. with a value of $11.5M.
Examining the 13F form we can see an increase of $21.8M in the current position value, from $245M to 267M.
Ghost Tree Capital, LLC is based out at New York, NY
Below you can find more details about Ghost Tree Capital, LLC portfolio as well as his latest detailed transactions.